The 3D printer Spanish manufacturer, BCN3D raises €2.8 million in funding round led by CDTI and Mondragon Group. While CDTI (the Spanish National Innovation Agency) invests through Innvierte, Mondragon invests through its venture capital fund managed by Clave Capital. The other investors who participated in the round are Accurafy4, JME Venture Capital, and Danobatgroup. This round of investment brings BCN3D’s total funding to €5.5 million since its spin-off in 2019 and will help the company enable development in new materials and hardware.

“We are excited to have the support of Mondragon. It will

allow us to strengthen our innovation plans for the workbench segment. I look forward to being part of this next phase of BCN3D, as we will accelerate the accessibility of 3D printing,” asserts Xavier Martinez Faneca, CEO at BCN3D.

The fund will be used to strengthen the development of new hardware features for the workbench segment on top of the BCN3D’s developed IDEX technology, the only extrusion system capable of printing with two heads independently. BCN3D will also use the fund to develop new industrial-grade materials designed to deliver outstanding results for the company’s printers in collaboration with BASF Forward AM and Mitsubishi Chemical.

“Not only does BCN3D perfectly fit our long-term strategy for the additive manufacturing industry with its vision to make 3D printing accessible, we firmly believe BCN3D can push the limits in the 3D printing industry,” says Alberto Bermejo, Investment Director at Clave Capital.

BCN3D has played an important role during this pandemic times. It has been working with healthcare providers, government organizations and their network of professionals on designing, prototyping and producing different vital parts for healthcare professionals.